• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

PamLabs LLC

Anonymous board for PamLabs LLC
Replies
108
Views
41K
anonymous
Replies
49
Views
23K
anonymous
Replies
0
Views
1K
anonymous
Replies
0
Views
2K
anonymous
Replies
0
Views
1K
anonymous
Replies
1
Views
1K
anonymous
Replies
6
Views
6K
anonymous
Replies
0
Views
3K
anonymous
Replies
4
Views
3K
anonymous
Replies
18
Views
11K
anonymous